Biodiversity loss, deforestation, ecosystem degradation. These manifestations of the anthropocene will have severe consequences for nature, society, and economies. While not yet fully recognized, biodiversity loss poses systemic and existential risks, including to investors and markets, for example threatening food supply chains, livelihoods, creating health risks (such as Covid-19), and significantly impacting climate degradation
So what business transformation is needed? In what sectors or regions? What role for investors vis a vis companies but also policymakers and stakeholders to preserve species, genetic wealth, nature and ecosystems? And what role for markets?
There has been growing interest in these issues among institutional investors, thanks to activists, to the work of IPBES, global visibility with the upcoming United Nations Biodiversity COP and, in this pandemic age, the links between zoonotic diseases and land use.
We are interested in identifying the specific areas and ways institutional investors can have an important and rapid intact, as well as lessons learned from the global climate action playbook.
This area is a work in progress. Please get in touch if you are interested in getting involved.